Economic evaluation of controlled-release oxycodone (oxycontin® tablets) (CRO) versus oxycodone/acetaminophen (percocet) (oxy/APAP) for osteoarthritis pain of the hip or knee

被引:0
|
作者
Marshall, DA
Strauss, ME
Pericak, D
Buitendyk, M
Codding, C
Kim, S
Torrance, G
机构
[1] Innovus Res Inc, Burlington, ON, Canada
[2] Purdue Pharma LP, Stamford, CT USA
[3] Oklahoma Sports, Oklahoma City, OK USA
关键词
D O I
10.1016/S1098-3015(10)62584-3
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:241 / 241
页数:1
相关论文
共 47 条
  • [21] Impact of controlled-release oxycodone on efficacy beliefs and coping efforts among osteoarthritis patients with moderate to severe pain
    Zautra, AJ
    Smith, BW
    CLINICAL JOURNAL OF PAIN, 2005, 21 (06): : 471 - 477
  • [22] Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: A double blind, randomized, multicenter, placebo controlled trial
    Caldwell, JR
    Hale, ME
    Boyd, RE
    Hague, JM
    Iwan, T
    Shi, MG
    Lacouture, PG
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (04) : 862 - 869
  • [23] A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee
    Spierings, Egilius L. H.
    Fidelholtz, James
    Wolfram, Gernot
    Smith, Michael D.
    Brown, Mark T.
    West, Christine R.
    PAIN, 2013, 154 (09) : 1603 - 1612
  • [24] Efficacy and safety of titration with controlled-release oxycodone versus immediate-release morphine in patients with moderate cancer pain
    Shi, Zhiyong
    Lou, Guangyuan
    Gu, Cuiping
    Song, Zhengbo
    Shao, Lan
    Zhang, Yiping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03): : 2595 - 2602
  • [25] Efficacy and safety of controlled-release versus immediate-release oxycodone: Randomized, double-blind evaluation in patients with chronic back pain
    Hale, ME
    Fleischmann, R
    Salzman, R
    Wild, J
    Iwan, T
    Swanton, RE
    Kaiko, RF
    Lacouture, PG
    CLINICAL JOURNAL OF PAIN, 1999, 15 (03): : 179 - 183
  • [26] Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain -: Placebo-controlled trial and long-term evaluation
    Roth, SH
    Fleischmann, RM
    Burch, FX
    Dietz, F
    Bockow, B
    Rapoport, RJ
    Rutstein, J
    Lacouture, PG
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (06) : 853 - 860
  • [27] Controlled-release oxycodone tablets after transdermal-based opioid therapy in patients with cancer and non-cancer pain
    Ravera, Enrico
    Di Santo, Salvatore
    Bosco, Rosa
    Arboscello, Claudio
    Chiarlone, Renato
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 23 (5-6) : 328 - 332
  • [28] Controlled-release oxycodone tablets after transdermal-based opioid therapy in patients with cancer and non-cancer pain
    Enrico Ravera
    Salvatore Di Santo
    Rosa Bosco
    Claudio Arboscello
    Renato Chiarlone
    Aging Clinical and Experimental Research, 2011, 23 : 328 - 332
  • [29] A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee: Response
    Spierings, Egilius L. H.
    Fidelholtz, James
    Wolfram, Gernot
    Smith, Michael D.
    Brown, Mark T.
    West, Christine R.
    PAIN, 2014, 155 (11) : 2432 - 2433
  • [30] Patient-controlled analgesia versus oral controlled-release oxycodone - Are they interchangeable for acute postoperative pain after laparoscopic colorectal surgeries?
    Ho, Hwee Shih
    ONCOLOGY, 2008, 74 : 61 - 65